tirzepatide hfpef trial Effects of on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity Lilly's Tirzepatide Reduces Heart Failure
Pay in 4 interest-free payments of $5.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Live Spec
Lilly's Tirzepatide Reduces Heart Failure Worsening for HFpEF With Obesity Cardiology Innovations Current Treatment of Heart Failure with Preserved Ejection Fraction In pts wiht HFpEF and obesity, tirzepatide (Mounjaro) significantly reduces HF hospitalization, diuretic intensification, or CV death by 38% vs placebo in SUMMIT trial https: t.co 8ZHm4gySiL Influence of Type 2 Diabetes on the Effects of Tirzepatide in Patients With Heart Failure and a Preserved Ejection Fraction With Obesity: A Prespecified Stratification Based Analysis JACC Effects of Tirzepatide in Obesity Related HFpEF by Sex: A Prespecified Secondary Analysis From the SUMMIT Trial ScienceDirect Effectiveness of tirzepatide in patients with HFpEF using a target trial emulation retrospective cohort study Nature Communications
Store: desimodels.in · Domain: desimodels.in























![Sword of Body and Mind [From the Vault: Relics] Penny](https://cdn.shopify.com/s/files/1/0270/4025/1974/products/2bc9f0a3-25aa-58c4-b43e-2ab5e52639ed_61e4a905-530e-4cd5-b563-2b651d280b18.jpg?v=1696363390)




